Pharmaceutical Intermediate Injected Peptide Powder Bpc- 157 99% Purity

China Pharmaceutical Intermediate Injected Peptide Powder Bpc-157 99% Purity, Find details about China Bpc-157, Pharmaceutical Intermediate from Pharmaceutical Intermediate Injected Peptide Powder Bpc-157 99% Purity

Model NO.
oroni
Transport Package
Box
Specification
powder
Origin
China
Model NO.
oroni
Transport Package
Box
Specification
powder
Origin
China
Detail Information 
Other name : Pentadecapeptide BPC 157 ; Booly Protection Compound 15
CAS: 137525-51-0 
MF: C62H98N16O22 
MW: 1419.53552 
Specification: 2mg/vial 
Appearance: White Lyophilized Powder 
Method of Analysis: HPLC 
Storage: Lyophilized peptides although stable at room temperature for 3 months, should be stored desiccated below -18°C. Upon reconstitution of the peptide it should be stored at 4°C between 2-21 days and for future use below -18°C
Pharmaceutical Intermediate Injected Peptide Powder Bpc-157 99% Purity

Description 
BPC 157 has a strong anti-inflammatory activity in both acute and chronic inflammation models. In fact, preliminary results in clinical trials suggest that BPC 157 may become an important therapeutic tool for the treatment of inflammatory bowel disease. BPC 157 was shown to accelerate wound healing and to have a marked angiogenic effect. In addition, it significantly facilitates the healing of bone fracture in rats. This peptide also exhibits an osteogenic effect significantly improving the healing of segmental bone defect. BPC 157 accelerates the healing of transected rat Achilles tendon and transected rat quadriceps muscle.
Pharmaceutical Intermediate Injected Peptide Powder Bpc-157 99% Purity

Storage :
Both mixed and unmixed vials should be stored in sealed plastic satchels or containers and
kept away from food in the refrigerator to prevent any risk of cross-contamination.